Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation

H Zhang, K Ma, W Liu, F Yang, J Liu, H Zhou - Gene, 2016 - Elsevier
Background Pharmacogenetics has provided compelling evidence towards the influence of
gene polymorphisms on warfarin therapies. This study aimed to determine the impact of …
被引用次数：17 相关文章

Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation

H Zhang, K Ma, W Liu, F Yang, J Liu, H Zhou - Gene, 2016 - infona.pl
Pharmacogenetics has provided compelling evidence towards the influence of gene
polymorphisms on warfarin therapies. This study aimed to determine the impact of CYP2C19 …

Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation.

H Zhang, K Ma, W Liu, F Yang, J Liu, H Zhou - Gene, 2016 - europepmc.org
Background Pharmacogenetics has provided compelling evidence towards the influence of
gene polymorphisms on warfarin therapies. This study aimed to determine the impact of …

Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation

H Zhang, K Ma, W Liu, F Yang, J Liu, H Zhou - Gene, 2016 - pubmed.ncbi.nlm.nih.gov
Background Pharmacogenetics has provided compelling evidence towards the influence of
gene polymorphisms on warfarin therapies. This study aimed to determine the impact of …

[引用][C] Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation

H Zhang, K Ma, W Liu, F Yang, J Liu, H Zhou - 2016